Warning: Declaration of My_Walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $data_object, $depth = 0, $args = NULL, $current_object_id = 0) in /home2/ajnrblog/public_html/ajnrdigest/wp-content/themes/ajnr/functions.php on line 258
Transverse Sinus Stenting for Idiopathic Intracranial Hypertension: A Review of 52 Patients and of Model Predictions - AJNR News Digest
June 2014
Interventional

Transverse Sinus Stenting for Idiopathic Intracranial Hypertension: A Review of 52 Patients and of Model Predictions

G. Michael Halmagyi

G. Michael Halmagyi

Geoffrey D. Parker

Geoffrey D. Parker

We chose this topic following the pioneering work of our colleague Dr. Ian Johnston, an eminent neurosurgeon who has struggled to unravel pseudotumor cerebri (PTC) for 40 years now.Our first success was in the late 1990s, when we treated a patient with PTC who had transverse sinus stenosis with balloon angioplasty. This patient had complete resolution of symptoms for several months before again becoming symptomatic.

We were also interested in the possible significance of giant arachnoid granulations in the pathogenesis of PTC, particularly after they were erroneously considered to be an incidental finding.2 Dr. Johnston provided a surgical specimen of a giant arachnoid granulation after resection of the transverse sinus for a dural arteriovenous fistula, and we published the results of histologic examination.3 We erroneously concluded that there was a heterotopic brain tissue within the granulation, but subsequent examination of the original slides showed that there was actually a large hernia of brain tissue into the granulation, expanding it. Another neurosurgeon, Dr. Michael Besser, then told us that small hernias of brain tissue into the stalk of an arachnoid granulation from the subarachnoid space were commonly seen during craniotomies.

At this point, “the penny dropped,” and we understood how rising intracranial pressure could enlarge a giant arachnoid granulation by enlarging the brain hernia, and this could then lead to increased venous sinus obstruction and upstream venous hypertension, with decreased CSF absorption and prolongation of elevated CSF pressure in defiance of normal negative feedback control of CSF pressure.

We realized that an abnormal positive feedback loop was operating in these patients with PTC, with venous hypertension leading to CSF hypertension and then further venous hypertension. We were then able to replicate this mechanism with a multicompartment mathematical model, following the work of Stevens et al.4 We were able to extend this understanding to patients with PTC and extrinsic transverse sinus stenoses due to collapsible sinuses (Starling resistors) and were able to understand why the conclusions of King et al,5 that the venous stenoses were simply secondary to raised intracranial pressure (and therefore should not be treated), were erroneous. It became clear that when one is faced with a positive feedback loop or a “vicious cycle,” the loop just needs to be broken and the answer to the question of causation becomes irrelevant—rather like the question of which came first: the chicken or the egg.

Since our publication, we have continued to stent the transverse sinus in patients with intractable PTC. We are now up to 127 patients, and as far as we can tell, there has been only one patient shunted for PTC at our hospital during this period.

Most patients have required only a single stent to reduce the venous pressure, reverse the papilledema, and abolish the tinnitus. A few needed a second stent at a later time, usually for continuing headache. We have also shown that stenting is much cheaper than shunting; while one stent costs about as much as one shunt, stents rarely need revision.6 There have been publications from at least 2 other groups about transverse sinus stenting,7,8 and their findings confirm our own. As far as we can tell only one other group in Australia stents; everyone else still shunts.

We have received much positive feedback and interest, though some has been negative, particularly from the neuro-ophthalmologists who believe that a randomized controlled trial is necessary before our results can be relied upon. Several other centers have commenced stenting for PTC in Europe and the US.

We are expanding this research into study of venous pressure waveforms in cerebral venography and longer follow-up of our stented patient cohort.

References

  1. Johnston I, Owler B, Pickard J. The Pseudotumor Cerebri Syndrome: Pseudotumor Cerebri, Idiopathic Intracranial Hypertension, Benign Intracranial Hypertension and Related Conditions. Cambridge University Press; 2007
  2. Roche J, Warner D. Arachnoid granulations in the transverse and sigmoid sinuses: CT, MR, and MR angiographic appearance of a normal anatomic variation. AJNR Am J Neuroradiol 1996;17:677–83
  3. Kollar C, Johnston I, Parker G, et al. Dural arteriovenous fistula in association with heterotopic brain nodule in the transverse sinus. AJNR Am J Neuroradiol 1998;19:1126–28
  4. Stevens SA, Previte M, Lakin WD, et al. Idiopathic intracranial hypertension and transverse sinus stenosis: a modelling study. Math Med Biol 2007;24:85–109, 10.1093/imammb/dql025
  5. King JO, Mitchell PJ, Thomson KR, et al. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002;58:26–30, 10.1212/WNL.58.1.26
  6. Ahmed RM, Zmudzki F, Parker GD, et al. Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting. AJNR Am J Neuroradiol published online before print November 28, 2013, 10.3174/ajnr.A3806
  7. Kumpe DA, Bennett JL, Seinfeld J, et al. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg 2012;116:538–48, 10.3171/2011.10.JNS101410
  8. Radvany MG, Solomon D, Nijjar S, et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuroophthalmol 2013;33:117–22, 10.1097/WNO.0b013e31827f18eb

 

Read this article at AJNR.org . . .